Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers

NCT03109847 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Thyroid

Interventions

DRUG: Metformin Hydrochloride
OTHER: Radioactive Iodine
OTHER: Placebo

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University